Pfizer Invites Public to View and Listen to a Webcast with Pfizer Director Joseph Echevarria to Discuss Board Oversight of ESG
Pfizer Director and Chair of the Governance and Sustainability Committee, Joseph Echevarria and Rady Johnson, Executive Vice President, Chief Compliance, Quality & Risk Officer, will discuss Board oversight of Environmental, Social and Governance matters.
Pfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to an on demand webcast with Pfizer Director and Chair of the Governance and Sustainability Committee, Joseph Echevarria and Rady Johnson, Executive Vice President, Chief Compliance, Quality & Risk Officer, discussing Board oversight of Environmental, Social and Governance matters at Pfizer. The webcast will be available beginning on Tuesday, February 1, 2022 at 10:00 a.m. Eastern Standard Time.
To view and listen to the webcast, visit our web site at www.pfizer.com/investors. Information on accessing and registering for the webcast will be available at www.pfizer.com/investors beginning today.
The transcript of the discussion will be made available on our web site at www.pfizer.com/investors within 24 hours after the end of the discussion.
About Pfizer: Breakthroughs That Change Patients’ Lives
At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products, including innovative medicines and vaccines. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as one of the world's premier innovative biopharmaceutical companies, we collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world.
For more than 170 years, we have worked to make a difference for all who rely on us. We routinely post information that may be important to investors on our website at www.Pfizer.com. In addition, to learn more, please visit us on www.Pfizer.com and follow us on Twitter at @Pfizer and @Pfizer News, LinkedIn, YouTube and like us on Facebook at Facebook.com/Pfizer.
Source: pfizer news
